CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluate the Feasibility of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Vaccine Administered as a 3 Dose Primary Vaccination Course at 6, 10 & 14 Weeks of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00291967
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:50.266461+00:00
Published At: 2006-12-08T00:00:00+00:00
Record Updated At: 2006-12-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diphtheria", "Tetanus", "Pertussis", "Hepatitis B", "Hib Diseases", "Neisseria Meningitidis Serogroups A \u0026 C Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2006-12-08"
protocolSection.identificationModule.nctId: "NCT00291967"
protocolSection.identificationModule.officialTitle: "Evaluate the Feasibility of GSK Biologicals\u0027 Tritanrix\u2122-HepB/Hib-MenAC Vaccine Administered as a 3 Dose Primary Vaccination Course at 6, 10 \u0026 14 Weeks of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.